CoreAge Rx vs Remote Pharmacy
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Remote Pharmacy head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Remote Pharmacy a bad call — it's best for readers comparing oral and injectable choices who can obtain the complete selected-term price and confirm their assigned care team. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Remote Pharmacy |
|---|---|---|
| Brief Score | 94/100 (A) | 66/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the full commitment Compounded injections advertised as low as $100/month; oral tablets from $167/month. Selected term and initial payment are unconfirmed; these are starting advertisements. Full price detailsComplete selected-term quote unknown; compounded semaglutide injections advertised as low as $100/month; oral tablets from $167/month, with plan commitment and initial total unconfirmed |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the full commitment Compounded injections advertised as low as $125/month; oral tablets from $257/month. Selected term and initial payment are unconfirmed; these are starting advertisements. Full price detailsComplete selected-term quote unknown; compounded tirzepatide injections advertised as low as $125/month; oral tablets from $257/month, with plan commitment and initial total unconfirmed |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ excludes Mississippi and New Mexico for compounded semaglutide and excludes US territories; other medication and pharmacy restrictions may apply |
| Brand-name access | Not confirmed | Ozempic and Wegovy are labeled coming soon on the current weight-loss catalog, not confirmed active options. |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Remote Pharmacy: Injection advertisements start at $100/$125 monthly; full selected-term totals remain unconfirmed. Cancellation after consultation but before shipment deducts $30.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.